In ₹ Crore except Per Share Latest Annual | LXCHEM FY26 | NEOGEN FY26 | NFL FY26 | PRIVISCL FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 59.49× | 219.08× | ◆ 16.12× | 41.52× | 41.52× +43% | |
| P/B | 2.38× | 7.72× | ◆ 1.20× | 9.44× | 7.72× -69% | |
| EV/EBITDA | 30.22× | 55.42× | ◆ 8.77× | 22.45× | 22.45× +35% | |
| Market Cap | ₹4,732 Cr | ₹6,300 Cr | ₹3,409 Cr | ₹13,598 Cr | ₹6,300 Cr -25% | |
| Growth | ||||||
| Revenue CAGR 3Y | 0.59% | 7.90% | -10.11% | ◆ 16.83% | 7.90% -93% | |
| Revenue CAGR 5Y | — | ◆ 20.70% | 12.56% | 14.96% | 14.96% | |
| Net Income CAGR 3Y | -13.96% | -16.83% | -22.73% | ◆ 145.99% | -16.83% +17% | |
| Revenue YoY (latest Q) | ◆ 39.75% | 34.04% | 27.34% | 19.22% | 27.34% +45% | |
| Net Income YoY (latest Q) | 216.56% | 66.76% | ◆ 387.47% | 43.94% | 66.76% +224% | |
| Profitability | ||||||
| EBITDA Margin | 6.02% | 15.96% | 3.87% | ◆ 25.21% | 15.96% -62% | |
| Net Income Margin | 2.79% | 3.34% | 0.98% | ◆ 12.35% | 3.34% -16% | |
| Return on Common Equity | 4.00% | 3.52% | 7.44% | ◆ 21.99% | 7.44% -46% | |
| Return on Capital Employed | 3.76% | 6.42% | 9.86% | ◆ 24.19% | 9.86% -62% | |
| Return on Assets | 2.30% | 0.99% | 1.80% | ◆ 9.99% | 1.80% +28% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.27× | 1.63× | 1.39× | 0.70× | 1.39× -81% | |
| Interest Coverage | 4.29× | 1.47× | 1.72× | ◆ 6.13× | 1.72× +149% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹2,847 Cr | ₹862 Cr | ₹21,514 Cr | ₹2,564 Cr | ₹2,564 Cr +11% | |
| Net Income | ₹79.4 Cr | ₹28.8 Cr | ₹211 Cr | ₹317 Cr | ₹211 Cr -62% | |
| Total Assets | ₹3,446 Cr | ₹2,902 Cr | ₹11,724 Cr | ₹3,170 Cr | ₹3,170 Cr +9% | |
| EPS | ₹2.87 | ₹10.9 | ₹4.31 | ₹83.85 | ₹10.9 -74% | |
| Book Value per Share | ₹71.66 | ₹309.42 | ₹57.91 | ₹368.79 | ₹309.42 -77% | |